LILRB1 and neoplasm: One such pathway that has been shown to impair macrophage‐mediated phagocytosis of tumor cells involves MHC class I signaling through the leukocyte immunoglobulin‐like receptor family member leukocyte immunoglobulin‐like receptor B1 (LILRB1).